No Result
View All Result
Success American Investors
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
No Result
View All Result
Success American Investors
No Result
View All Result
Home Investing

HMRC targets specialist agents in crackdown on R&D tax credit fraud

by
November 18, 2024
in Investing
0
HMRC targets specialist agents in crackdown on R&D tax credit fraud
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Claims for multibillion-pound business tax incentives are more likely to be non-compliant when submitted with the assistance of specialist agents, according to an official review by HM Revenue & Customs (HMRC).

An inquiry into research and development (R&D) tax credits—schemes intended to encourage innovation but undermined by fraud and error—found that behaviour among some agents was “clearly not acceptable”.

In its review of incentives for business innovation, HMRC estimated that fraud and error in these taxpayer-funded schemes amounted to £4.1 billion between 2020 and April this year. The tax reliefs, designed to support companies working on science and technology projects, cost the UK about £8 billion annually.

A 2022 investigation by The Times revealed how advisers were encouraging companies to make dubious claims, many of which went unchecked by HMRC. Examples included claims for creating a vegan menu in a pub.

In response, HMRC has increased scrutiny on claims and implemented several reforms to the scheme’s rules. A document published alongside last month’s budget stated that data from a “mandatory random inquiry programme” found that almost one in three claims in its sample were “fully disallowed” because “no qualifying R&D took place”.

Overall, HMRC estimated that in 2021-22, over one in four claims under the scheme for small and medium-sized enterprises were due to fraud and error. By the most recent financial year, this figure had improved to about one in seven.

While agents are expected to help companies file accurate claims, HMRC’s inquiries revealed that “non-compliance was slightly higher in those claims that were submitted with the support of a specialist R&D agent”.

HMRC acknowledges the “vital role” agents play but noted that some “provide poor or incorrect advice to customers about what they are entitled to claim. This can lead to spurious R&D tax relief claims being submitted by customers themselves or by agents on their behalf, thereby increasing non-compliance”.

The review identified several sectors where “R&D is unlikely” but which were being “approached by unscrupulous agents”. These include care homes, childcare providers, personal trainers, wholesalers, retailers, pubs, and restaurants. Error was said to be a bigger problem than fraud.

To address this, HMRC has been running education campaigns, writing to thousands of companies to explain the qualifying criteria for R&D tax credits.

Companies in sectors traditionally associated with R&D investment have reported difficulties obtaining incentives since HMRC’s crackdown. Research by RSM UK, the accountancy and audit firm, found that more than a third of technology businesses had submitted an R&D claim that was initially approved but later challenged by HMRC, resulting in companies needing to make repayments.

David Blacher, partner at RSM UK, commented: “The increased focus on weeding out erroneous claims has been detrimental to those genuinely in need of funding.”

Read more:
HMRC targets specialist agents in crackdown on R&D tax credit fraud

Previous Post

Goodstack raises £22m as corporate giving platform targets £2.4bn in employee donations

Next Post

Begbies Traynor predicts surge in insolvencies following budget impact

Next Post
Begbies Traynor predicts surge in insolvencies following budget impact

Begbies Traynor predicts surge in insolvencies following budget impact

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!
  • Trending
  • Comments
  • Latest
Vertica: The new Israeli start-up challenger to Viagra proving ‘life-changing’ for men with ED

Vertica: The new Israeli start-up challenger to Viagra proving ‘life-changing’ for men with ED

February 14, 2024

Last Day to Give in 2023!

December 31, 2023
Idaho Bucks Managed Care Trend

Idaho Bucks Managed Care Trend

December 5, 2023

The Producer Price Index

September 9, 2023
A Disappointing Supreme Court Decision Weakens Online First Amendment Protections

A Disappointing Supreme Court Decision Weakens Online First Amendment Protections

0

0

0

0
A Disappointing Supreme Court Decision Weakens Online First Amendment Protections

A Disappointing Supreme Court Decision Weakens Online First Amendment Protections

June 27, 2025
Brazil’s Supreme Court Rewrites the Rules to Censor Online Speech

Brazil’s Supreme Court Rewrites the Rules to Censor Online Speech

June 27, 2025
The Supreme Court Is Right on Reading Opt-Outs, But That’s Not Enough

The Supreme Court Is Right on Reading Opt-Outs, But That’s Not Enough

June 27, 2025
Friday Feature: Savannah Legacy Academy

Friday Feature: Savannah Legacy Academy

June 27, 2025

Recent News

A Disappointing Supreme Court Decision Weakens Online First Amendment Protections

A Disappointing Supreme Court Decision Weakens Online First Amendment Protections

June 27, 2025
Brazil’s Supreme Court Rewrites the Rules to Censor Online Speech

Brazil’s Supreme Court Rewrites the Rules to Censor Online Speech

June 27, 2025
The Supreme Court Is Right on Reading Opt-Outs, But That’s Not Enough

The Supreme Court Is Right on Reading Opt-Outs, But That’s Not Enough

June 27, 2025
Friday Feature: Savannah Legacy Academy

Friday Feature: Savannah Legacy Academy

June 27, 2025

Disclaimer: SuccessAmericanInvestors.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

  • About us
  • Contact us
  • Privacy Policy
  • Terms & Conditions

Copyright © 2025 SuccessAmericanInvestors. All Rights Reserved.

No Result
View All Result
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock

Copyright © 2025 SuccessAmericanInvestors. All Rights Reserved.